Transcutaneous Auricular Vagus Nerve Stimulation in Dry Eye

NARecruitingINTERVENTIONAL
Enrollment

256

Participants

Timeline

Start Date

July 1, 2021

Primary Completion Date

November 1, 2025

Study Completion Date

December 1, 2025

Conditions
Dry Eye Disease
Interventions
DEVICE

Transcutaneous Auricular Vagus Nerve Stimulation

"taVNS device (Elmmedicare, EC100, Shenzhen, China) was used to apply stimulation for patients.~Stimulation parameters comprised an electrical current of 1 mA at a frequency of 20 Hz, with a waveform width of 1 ms. Repurposed off-the-shelf devices were utilized for this purpose, with the stimulator generating single square-wave pulses lasting 1 ms each. Enhancing conductivity was achieved by wiping the ear with tap water. The electrodes were placed on the cymba conchae and concha around the affected ear, which is the region of rich vagus nerve branch distribution."

DRUG

0.1% sodium hyaluronate eye drop

Participants received 0.1% sodium hyaluronate eye drop (HYLO COMOD® eye drops, Ursapharm, Ltd., Germany).

Trial Locations (1)

100730

RECRUITING

China Beijing TongRen Hospital, Capital Medical University Beijing, China, Beijing

All Listed Sponsors
lead

Beijing Tongren Hospital

OTHER